Amandala Neuro

Amandala Neuro is a London-based clinical-stage biopharmaceutical company pioneering short-acting psychedelic treatments for unmet psychiatric needs. The company is developing patient-centered therapies designed to integrate within established psychiatric care settings. Specific drug candidates and clinical programs have not yet been publicly disclosed.